In Phase C, members will acquire ABBV-744 and oral navitoclax. In Phase D, members will get ABBV-744 and ruxolitinib. Members will get treatment till condition progression or perhaps the individuals are unable to tolerate the study drugs. Ubiquitin-similar proteins that control the stability of important Tremendous enhancer-mediated proteins have also https://abbv-744combinationtherap14679.qodsblog.com/32047856/the-2-minute-rule-for-abbv-744-and-other-brd4-inhibitors-comparison